Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MoLO study
2008-007765-23Phase 3Terminated
- Sponsor
- Società Italiana Malattie Infettive e Tropicali
- Start
- Dec 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lopinavir and ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Società Italiana Malattie Infettive e Tropicali. Primary endpoint: Average annual cost/benefit. Started Dec 2009; status: terminated.
02
Drugs
lopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-007765-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007765-23.